Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy

NCT02003599 is registered in ClinicalTrials.gov with Universidade do Vale do Sapucai as lead sponsor.

NCT NCT02003599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02003599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy
Lead sponsor
Universidade do Vale do Sapucai
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
March 31, 2015
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, radiotherapy; adverse effect, dermatitis or eczema